UPDATE 1-Hospira gets FDA warning letter for Italian facility

April 7, 2015 4:59 PM

6
0

April 7 (Reuters) - Hospira Inc, which agreed in February to be bought by Pfizer Inc, said the U.S. Food and Drug Administration had sent it another warning letter detailing violations in standard drug manufacturing practices at one of its facilities.

The FDA said its inspectors had visited the company's plant in Liscate, Italy twice in May last year and identified significant violations, including a failure to establish procedures to prevent contamination and to thoroughly investigate instances where a batch did not meet specifications.